DINO Bounces, but the CEO's Open-Market Bet Is the Real Story

HF Sinclair reported Q3 results on October 28 and fell nearly 9% on the day, closing around $114. By Friday it had recovered to $115, up 2.8% on the session. The rebound brings it back into positive territory for the month, but the stock is still down more than 5% on the week, lagging most of its refining peers: VLO fell 3.9% over the same period, MPC lost 2.7%, and PBF actually gained 2.4%. The recovery is real, but the relative underperformance has not closed.

The most concrete signal in the data is CEO Franklin Myers buying $1.1 million of stock in the open market on October 29, the day after the earnings drop, at $110.80 per share. That follows a $1.28 million open-market purchase in August at $85.30. Neither trade was made under a pre-arranged 10b5-1 plan. Net insider buying over the past 90 days totals roughly $1.6 million, with the CEO accounting for the bulk of it. In a sector where the standard CEO transaction is a compensation grant or an option exercise, two unsolicited cash purchases bracketing an earnings selloff carry more weight than the routine filings that dominate the Form 4 register.

The analyst picture is split in a way that has not resolved since the Q3 print. Piper Sandler assumed coverage the morning of the earnings report with an Overweight and a $152 target, the highest on the Street. Goldman Sachs is at $142 with a Buy, and Raymond James has a Strong Buy at $140. Against that, TD Cowen kept its Hold at $110, which sits below where the stock is trading now, and Evercore ISI and Barclays both hold neutral-leaning ratings in the $110 to $122 range. The consensus mean target of roughly $123 is barely above the current price. The core disagreement is whether operational recovery in refining and lubes materialises in Q4 and into 2026, or whether execution risk and the management transition keep a lid on the multiple. The EV/EBITDA multiple has compressed about 11% over the past 30 days, which puts the valuation argument more firmly in the bulls' favour than it was a month ago.

REH Advisors, which filed a Schedule 13D in 2025, trimmed its stake from 6.3% to 5.1% as of August, and the most recent institutional data shows a further reduction. That is worth noting alongside the CEO buying: the largest activist-style holder is selling down, while management is adding. Both are "as last disclosed" figures, and either party may have moved since filing.

Short interest is modest at 3.8% of the float and has fallen roughly 30% over the past month, a genuine reduction in bearish positioning. Borrow is cheap at 0.39%, and availability is effectively unconstrained. That combination means the lending market is placing no pressure on the stock in either direction. Options positioning is equally calm: the put/call ratio of 0.55 is fractionally below its 20-day average and well within normal range.

ORTEX forecasts a 60% probability that the spinoff of HF Sinclair's Lubricants and Specialties segment triggers a share-count reduction in the S&P MidCap 400, Russell 1000 and Russell 3000, though dates are estimated and no announcement from the index providers has been made. That structural overhang may be part of why institutional flows have been mixed even as targets have moved higher.

The November 5 print, now confirmed, will test whether the Q3 operational weakness in refining and lubes was the trough or merely the latest in a series of quarters where results have fallen short of what the target prices imply.